Onderneming Acarix AB (publ) Nasdaq Stockholm
Aandelen
SE0009268717
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cardiovascular Diagnostic Method and Associated Equipment
100,0
%
| 6 | 100,0 % | 6 | 100,0 % | +7,20% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
58,4
%
| 2 | 31,2 % | 4 | 58,4 % | +100,27% |
Germany
35,7
%
| 3 | 57,2 % | 2 | 35,7 % | -32,99% |
Sweden
3,0
%
| 0 | 6,8 % | 0 | 3,0 % | -53,05% |
Other
2,4
%
| 0 | 0,2 % | 0 | 2,4 % | +1.577,78% |
Austria
0,5
%
| 0 | 2,6 % | 0 | 0,5 % | -79,22% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 60 | 01-01-07 | |
Director of Finance/CFO | 60 | 01-01-16 | |
Jennifer Matson
CTO | Chief Tech/Sci/R&D Officer | 47 | 01-01-22 |
Chief Operating Officer | 50 | 01-01-22 | |
Tobias Fritz
CTO | Chief Tech/Sci/R&D Officer | 45 | 01-01-21 |
Public Communications Contact | 45 | 01-01-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 51 | 11-05-21 | |
Ulf Rosén
BRD | Director/Board Member | 64 | 01-01-14 |
Director/Board Member | 70 | 11-05-21 | |
Director/Board Member | 59 | 01-01-20 | |
Mikael Thoren
BRD | Director/Board Member | 60 | 01-01-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 737 188 816 | 649 218 759 ( 88,07 %) | 0 | 88,07 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-42,33% | 2,84 mld. | |
+17,00% | 1,85 mld. | |
-0,51% | 1,66 mld. | |
+27,15% | 1,26 mld. | |
-13,90% | 989 mln. | |
-21,76% | 896 mln. | |
-2,72% | 757 mln. | |
-23,95% | 637 mln. | |
+6,84% | 500 mln. |